Transcytosis of lipoprotein lipase across endothelial cells requires both heparan sulfate proteoglycans and the VLDL receptor.
No takes yet. Share an insight, caveat, or question.
No immediate clinical implications; leaves open whether HSPG-VLDL receptor pathways mediate LPL transcytosis in humans.
Obunike et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: